Sedative medications for pediatric fiberoptic bronchoscopy
Conditions
Interventions
Test group:If the response is in the negative group, no further intervention is made, and the remimazolam dose for the next pediatric patient is decreased by 0.01 mg/kg. If the response is in the posi
Sponsors
Cangzhou Central Hospital
Eligibility
Sex/Gender
All
Age
6 Years to 12 Years
Inclusion criteria
Inclusion criteria: 1. Patients aged 6-12 years; 2. American Society of Anesthesiologists (ASA) physical status classification I to II; 3. No contraindications to the anesthetic methods used in the study; 4. No history of allergy to the medications used; 5. Voluntarily signed informed consent form; 6. Fasting for >=6 hours and no oral liquids for >=2 hours.
Exclusion criteria
Exclusion criteria: 1. History of long-term use of psychotropic medications, sedative analgesics, anticoagulants, or other relevant drugs; 2. Allergy to the investigational drug(s) or history of severe allergic reactions to anesthetics; 3. History of abnormal recovery from previous surgical anesthesia; 4. Severe dysfunction of vital organs (e.g., heart, lung, liver, or kidney); 5. Participation in other drug trials within the past 3 months; 6. History of myasthenia gravis, bronchial asthma, schizophrenia, or major depressive disorder.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Half Effective Dose; | — |
Secondary
| Measure | Time frame |
|---|---|
| cough;involuntary movement;heart rate; | — |
Countries
China
Contacts
Public ContactHu Shuaipeng
Cangzhou Central Hospital
Outcome results
None listed